期刊文献+

彩虹明樱蛤多糖对转染HBV的HepG2细胞表达功能的影响 被引量:4

Study of the effects of Moerella iridescens polysaccharide on hepatitis B virus transfected HepG2 cells
下载PDF
导出
摘要 目的研究彩虹明樱蛤多糖(MIP)对转染HBV的HepG2细胞表达功能的影响。方法以不同浓度(10^-3-104μg/m1)MIV作用于体外培养的HepG2.2.15细胞,采用MTT法、时问分辨免疫分析法(TRFIA)和ELISA法检测MIP对HepG2.2.15细胞的毒性作用及HBsAg、HBeAg、Pre-SlAg表达的影响,采用FQPCR检测MIP对HBVDNA复制的抑制作用。结果MIP在10^-2~10μg/ml浓度范围内对HepG2.2.1s细胞无毒性作用,TC50为4633μg/ml。MIP在10^-2~102μg/ml浓度范围内,对HBsAg、HBeAg、Pre-S1AgDA及HBVDNA均有一定抑制作用,相应的治疗指数分别为129、28、20和83。结论MIP具有一定的抗HBV活性。 Objective To investigate the effects ofMoerella iridescens polysaccharide (MIP) on Hepatitis B virus (HBV) transfected HepG2 cells. Methods HepG2.2.15 cells were treated with different concentrations of MIP (10 2-104μg/ml), and they were cultured in vitro. The MTT assay, time-resolved fluoreimmunoassay (TRFIA), and enzyme-linked immunosorbent assay (ELISA) were used to explore the cytotoxic effect of MIP on HepG2.2.15 cells and its effects on HBsAg, HBeAg, and Pre-SIAg secreted by HepG2.2.15 cells. The fluorescence quantitative PCR (FO,:PCR) was employed to evaluate the inhibitory effects of MIP on the duplication of HBV-DNA. Results The results indicated that MIP had no clear cytotoxic effect on HepG2.2.15 cells in the concentrations from 10-2μg/ml to 102μg/ml, and the TCs0 of MIP was 4,633μg/m-k MIP has Some inhibitory effects in the concentrations from 10-2μg/ml to 102μg/ml on HBsAg, HBeAg, Pre-SIAg, and HBV-DNA. The therapeutic indices (TI) of MIP on HBsAg, HBeAg, Pre-SIAg, and HBV-DNA were 129, 28, 20, and 83, respectively. Conclusions MIP has a certain dose- dependent inhibitory effect on HBsAg, HBeAg, Pre-S1Ag, and HBV-DNA in the culture supernatant fluid of HepG2.2.15 cells; there is a dose-effect relationship, which shows that MIP has some anti-HBV activities.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2012年第2期109-112,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(30872367)~~
关键词 彩虹明樱蛤多糖 肝炎 乙型 慢性 HEPG2细胞 Moerella iridescens polysaccharide hepatitis B virus HepG2 cell
  • 相关文献

参考文献9

  • 1Papatheodoridis GV,Manolakopoulos S,Dusheiko G,etal.Therapeutic strategies in the management of patients withchronic hepatitis B virus infection[J].Lancet Infect Dis,2008,8(3):167-178.
  • 2刘妍,王春梅,李绵洋,王琳,程勇前,张玲霞,徐东平.miR-181a在转染乙型肝炎病毒基因组的HepG2.2.15细胞中的表达研究[J].解放军医学杂志,2008,33(8):992-994. 被引量:3
  • 3向维,陈松华,李朝品.彩虹明樱蛤多糖对小鼠急性化学性肝损伤的保护作用[J].中国生化药物杂志,2012,33(1):43-45. 被引量:13
  • 4向维,陈松华,李朝品.彩虹明樱蛤多糖对小鼠的免疫调节作用[J].中国生化药物杂志,2011,32(5):393-395. 被引量:9
  • 5Pichoud C,Berby F,Stuyver L,etal.Persistence of viralreplication after anti-Hbe seroconversion during antiviraltherapy for chronic hepatitis B[J].J Hepatol,2000,32(2):307-316.
  • 6Wang NY,Zhang D,Zhao W,etal.Hepatitis B virus largesurface protein in serum as a candidate biomarker for evaluatinghepatitis B virus infection[J].Clin Biochem,2011,44(14):1199-1204.
  • 7Leonard WJ.Role of Jak kinases and STATs in cytokine signaltransduction[J].Int J Hematol,2001,73(3):271-277.
  • 8Bhunia AK,Piontek K,Boletta A,etal.pKDI induces P21 andregulation of the cell cycle via direct activation of the JAK-STATsignaling pathway in a process requiring PKD2[J].Cell,2002,109(2):157-168.
  • 9Joo SS,Won TJ,Kim MJ,etal.Interferon signal transductionof biphenyl dimethyl dicarboxylate/amantadine and anti-HBVactivity in HepG2.2.15[J].Arch Pharmacal Res,2006,29(5):405-411.

二级参考文献21

共引文献18

同被引文献43

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部